The Valley Desk

NCT02590432 · Interventional trial

An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

Overall registry status Completed

Phase 4

Conditions Chronic Idiopathic Constipation, Irritable Bowel Syndrome With Constipation

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov